Viridian Therapeutics, Inc. (VRDN) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$10,505
Total Return
5.05%
CAGR
0.99%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +2.25% |
| Median | -0.52% |
| Best | +87.77% |
| Worst | -51.89% |
| % of Windows Positive | 48.3% |
1-Year (252 Trading Days)
| Average | +14.82% |
| Median | +5.27% |
| Best | +165.67% |
| Worst | -56.23% |
| % of Windows Positive | 52.9% |
3-Year (756 Trading Days)
| Average | +3.74% |
| Median | +0.15% |
| Best | +97.55% |
| Worst | -45.73% |
| % of Windows Positive | 50.0% |
Risk Metrics
| Maximum Drawdown | -70.69% |
| Average Drawdown | -35.23% |
| Drawdown Duration | 805 Trading Days (Unrecovered) |
| Sortino Ratio | 0.55 |
| Calmar Ratio | 0.01 |
| CVaR (5%) | -8.68% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -51.19% (-91.95% ann.) | $5118.95 | $0.00 | $0.00 | $0.00 |
| 2025 | +62.34% | +$6233.86 | $0.00 | $0.00 | $0.00 |
| 2024 | -11.98% | $1198.23 | $0.00 | $0.00 | $0.00 |
| 2023 | -25.44% | $2543.76 | $0.00 | $0.00 | $0.00 |
| 2022 | +47.76% | +$4775.50 | $0.00 | $0.00 | $0.00 |
| 2021 | +20.18% | +$2017.90 | $0.00 | $0.00 | $0.00 |
| 2020 | +128.49% | +$12849.43 | $0.00 | $0.00 | $0.00 |
| 2019 | -84.16% | $8415.98 | $0.00 | $0.00 | $0.00 |
| 2018 | -70.95% | $7094.94 | $0.00 | $0.00 | $0.00 |
| 2017 | +108.18% | +$10818.09 | $0.00 | $0.00 | $0.00 |
| 2016 | -55.35% | $5534.71 | $0.00 | $0.00 | $0.00 |
| 2015 | -70.55% | $7055.13 | $0.00 | $0.00 | $0.00 |
| 2014 partial | -72.06% (-90.71% ann.) | $7205.72 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | June 18, 2014 – February 19, 2020 | -99.37% | -59.06% | $9936.93 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -53.85% | -99.99% | $5385.08 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +161.29% | +368.98% | +$16128.81 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +6.02% | +5.70% | +$602.15 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -1.35% | -1.43% | $135.01 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +6.97% | +3.70% | +$697.24 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | -27.87% | -18.80% | $2787.22 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.